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Abstract
Background: This needs assessment, initiated by the Academy for Healthcare Education Inc. in
cooperation with AXDEV Group Inc., explored the knowledge, attitudes, behavior, and skills of
community-based and academic-affiliated U.S. cardiologists in the area of CV risk assessment,
treatment, and management from July 2006 to December 2006.
Methods: The needs assessment used a multistage, mixed-method approach to collect, analyze,
and verify data from two independent sources. The exploratory phase collected data from a
representative sampling of U.S. cardiologists by means of qualitative panel meetings, one-on-one
interviews, and quantitative questionnaires. In the validation phase, 150 cardiologists from across
the United States completed a quantitative online questionnaire. Data were analyzed with
standardized statistical methods.
Results: The needs assessment found that cardiologists have areas of weakness pertaining to their
interpersonal skills, which may influence patient-physician communication and patient adherence.
Cardiologists appeared to have little familiarity with or lend little credence to the concept of
relative CV risk. In daily clinical practice, they faced challenges with regard to optimal patient
outcome in areas of patient referral from primary-care providers, CV risk assessment and
treatment, and patient monitoring. Community-based and academic-affiliated cardiologists
appeared to be only moderately interested in educational interventions that pertain to CV risk-
reduction strategies.
Conclusion: Educational interventions that target cardiologists' interpersonal skills to enhance
their efficacy may benefit community-based and academic-affiliated specialists. Other desirable
educational initiatives should address gaps in the patient referral process, improve patient
knowledge and understanding of their disease, and provide supportive educational tools and
materials to enhance patient-physician communication.
Background
The health and survival benefits of optimizing the treat-
ment of cardiovascular disease (CVD) risk factors are
undeniable, based on the results of both observational
and randomized controlled trials [1]. Several meta-analy-
ses and cost-benefit analyses of risk-factor reduction,
including blood pressure (BP) reduction [2], cholesterol
lowering [3,4], increased physical activity [5], glucose
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control in diabetics [6], weight loss among obese individ-
uals [7], and smoking cessation [8,9] have revealed signif-
icant reductions in a wide variety of CVD endpoints,
including myocardial infarction (MI) and stroke, health-
care expenditures, and death [1].
The Framingham Heart Study and other studies have elu-
cidated the quantitative relationship between CV risk fac-
tors and CHD [10]. These studies show that the major risk
factors are additive in predictive power, but any major risk
factor, if left untreated for many years, has the potential to
produce CVD.
Knowledge about the detection, treatment, and control of
cardiovascular (CV) risk factors provides the impetus and
rationale for the prevention of cardiovascular disease
(CVD)[1]. Effective prevention of CVD requires an ade-
quate risk-factor assessment to categorize patients for the
selection of appropriate therapeutic intervention [11]. In
clinical practice, CV risk factors are identified and treated
in those not yet ill (primary prevention) and among peo-
ple with established CVD to prevent recurrent events (sec-
ondary prevention) by means of widely disseminated
clinical practice guidelines [12,13]. Professional cardiol-
ogy associations worldwide, including the American
Heart Association (AHA) and American College of Cardi-
ology (ACC), have established guidelines to stress the
importance of CV risk-factor assessment, treatment, and
management. However, virtually every study of preventive
therapies has shown that physicians do not actively pur-
sue the goals of prevention outlined in these guidelines
[1].
With the emergence of outcome-based educational initia-
tives, needs assessments of practicing healthcare profes-
sionals have become a primary tool for identifying gaps
and barriers to change in daily clinical practice. The
rationale for a comprehensive needs assessment is to help
those who provide educational and supportive programs
to understand the what, how, and why of clinical deci-
sion-making behaviors. Analysis of a behavioral needs
assessment reveals the differences between actual activi-
ties in daily clinical practice as compared to optimal clin-
ical practices, i.e., "what is happening" versus "what
should be happening", as indicated by evidence-based
medicine, clinical practice guidelines, clinical research,
and experts in the field, i.e., key opinion leaders.
The Academy for Healthcare Education Inc. embraced this
research paradigm by partnering with Axdev Group Inc.,
an educational and performance research organization
that actively supports healthcare research and educational
initiatives, to conduct a comprehensive behavioral
national needs assessment of practicing U.S. community-
based and academic-affiliated cardiologists from July
2006 to December 2006.
The objective of this research initiative was to assess the
clinical approaches of practicing cardiologists to CV risk-
factor assessment, treatment, and management in order to
identify knowledge gaps and major barriers to change that
interfere with the adoption of preventive strategies in
daily clinical practice. The goals was to provide specific,
targeted recommendations to educational program devel-
opers to aid in the design of effective educational pro-
grams for practicing cardiologists to enhance best clinical
practices in CV risk assessment, treatment, and manage-
ment. A sub-research objective of this study was to exam-
ine the role of clinical practice guidelines in the
assessment, treatment, and management of CV risk factors
and to understand the extent to which cardiologists prac-
tice "beyond" or "outside" of guidelines.
Methods
This needs assessment employed an applied cognitive
behavioral design that embodies triangulation [14,15].
This design ensures the reliability and trustworthiness of
the assessment by integrating qualitative and quantitative
data-collection techniques in a mixed-methods approach
(Table 1). Triangulation is defined as a method of research
Table 1: Mixed methods approach
Study design ▪ A literature search and environmental scan were conducted to inform the design of the study and guide the 
development of the qualitative and quantitative research tools.
▪ Research design and rationale, research tools, participant informed consent processes, and materials were 
submitted for ethics review to an Institutional Review Board (IRB). The ethics review was approved June 2006 
(exploratory phase) and December 2006 (validation phase).
Exploratory phase (Qualitative) ▪ Panel meetings and key informant interviews were conducted with two selectively sampled groups of 
participants (actively practicing, academic-affiliated, and community-based cardiologists).
Validation phase (Quantitative) ▪ Online quantitative questionnaire, informed by the exploratory phase, was distributed to a national sample of 
actively practicing cardiologists.
Analysis ▪ Analysis, interpretation, conclusions, and recommendations based on multidisciplinary team collaboration and 
input.BMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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design that strengthens the study by using a combination
of methodologies in the examination of the same phe-
nomena. Overall, the rationale behind the mixed-meth-
ods approach is based on the logic that no single data-
collection method adequately solves the problem of rival
causal factors [16,17]. Because each method reveals differ-
ent aspects of empirical reality, multiple methods of
assessment are employed to ensure the trustworthiness of
findings.
The exploratory phase of data collection relied on semi-
structured, qualitative, data-collection techniques and
quantitative self-completion questionnaires among a
small, representative sample of practicing community-
based and academic-affiliated cardiologists. The valida-
tion phase employed a standardized online question-
naire, which was designed on the basis of findings from
the exploratory phase. During the validation phase, strict
sampling procedures were used to ensure a representative
sample of practicing U.S. cardiologists.
Sampling
Data collection during the exploratory phase occurred at
full-day panel meetings in New York City, which were
conducted with two homogenous groups of participants:
academic-affiliated cardiologists (n = 11), who practice
primarily in teaching hospitals, and community-based
cardiologists (n = 9), who work primarily in non-teaching
hospitals (Table 2). The majority of the participating car-
diologists currently practice in the New England and Mid-
dle Atlantic regions.
The panel meetings were semi-structured and included (a)
democratic group discussion regarding cardiologists'
roles; their issues and challenges in CV risk assessment,
treatment, and management; CV residual risk; and contin-
uing professional development (CPD) needs; (b) nomi-
nal group processes to establish cardiologists' priorities to
enhance their clinical practice; and (c) a self-completion
questionnaire designed to explore their learning needs,
preferred learning formats, and perceived barriers to opti-
mal CV risk assessment, treatment, and management.
Throughout the process, the participants were asked to
reflect upon their issues, challenges, and barriers in the
continuum of care for patients with CV risk factors.
In addition to the full-day meetings, key informant (KI)
interviews were conducted with an additional sampling of
cardiologists (5 academic-affiliated cardiologists and 12
community-based cardiologists) from across the country.
This sampling served to cross-validate the findings of the
full-day meetings. The KI interviews followed a format
similar to the panel meetings, but participants were inter-
viewed in isolation. The semi-structured, audiotaped tele-
phone KI interviews explored the same themes as the
panel meetings. The participants of panel meetings and
key informant interviews also completed a quantitative
questionnaire.
The findings from the exploratory phase were used to
guide the development of an online quantitative ques-
tionnaire, which was used during the validation phase. In
this phase, 75 academic-affiliated cardiologists and 75
community-based cardiologists completed the online sur-
vey. These cardiologists were equally distributed across
the country to ensure representation from the four major
regions of the USA and were sampled to represent cardiol-
ogists who actively treat and manage patients with CV risk
factors (Table 3). The participants responded to quantita-
tive questions about gaps and barriers in CV risk assess-
ment, treatment, and management that were identified in
the exploratory phase and to assess their readiness to
change.
Data collection and analysis
Qualitative and quantitative data were collected by four
distinct methods: panel meetings, individual interviews,
self-completion forms, and an online survey. The result-
ing data were examined by multiple methods of analysis.
Qualitative data from panel meetings were captured via
flip charts and audiotapes, which were transposed by
independent transcribers. All data were then categorized;
axial and multidisciplinary coding was applied and tabu-
lated by structured qualitative methods. The self-comple-
tion forms and data from the online survey were
statistically analyzed by SPSS software, which assessed fre-
quencies, t-tests, cross tabulations, and gap analyses.
Table 2: Study participants
Academic-affiliated cardiologists Community-based cardiologists Total
Exploratory phase
Full-day meetings 11 9 20
Key informant interviews 5 12 17
Validation phase
Online survey 75 75 150
Total 91 96 n = 187BMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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Results
The multidisciplinary analysis of findings from this needs
assessment revealed that cardiologists face substantive
challenges, issues, and gaps in CV-risk assessment, treat-
ment, and management in their daily clinical practice,
including treating across the continuum of care; the clini-
cal application of professional guidelines; the manage-
ment of CV residual risk; the patient-doctor relationship
and patient adherence; and in their professional develop-
ment needs.
Professional challenges along the continuum of care
Referrals from primary-care physicians
According to cardiologists, substantive contributing fac-
tors in the referral process prevent the achievement of
optimal patient health outcomes. They reported that
patient referrals from primary-care physicians (PCPs)
range from ambiguous to lacking in critical information;
hence, the quality of PCP referrals was marred by distrust.
They reported that PCP referrals are often inappropriately
timed, e.g., too early or too late in the progression of CV
risk factors, and lack clarity as to purpose or expected
patient outcome.
The cardiologists reported that they receive two major
types of inappropriate referral from PCPs: at-risk patients
who could easily be cared for in primary practice; and
complex patients, whom PCPs have little commitment or
interest in managing due to the time investment that is
required for patient management, although their training
allows them to do so. The cardiologists also reported that
PCPs delay appropriate referrals until patient health has
substantively deteriorated; therefore, cardiologists receive
these patients too late to impact their health outcome
(Figure 1).
The quality of clinical information that cardiologists
receive from PCPs was perceived as rarely optimal. In
referral letters, patient history is often vague, the rationale
for the referral is not always clearly communicated, and
the patients themselves are often not informed and are
therefore cannot explain the reason for their referral. Both
academic-affiliated and community-based cardiologists
shared these perceptions.
To summarize, cardiologists perceived the processes cur-
rently in place to facilitate their collaboration with PCPs
as barriers to optimal clinical performance, as exemplified
by the following statements.
"They're [referrals] inappropriate because the physician [PCP]
hasn't done what should have been done. Let me say this, if you
look at it like fruit, this is an unripe referral." Community-
based cardiologist.
"Frequently, you're just getting a piece of paper that says the
diagnosis and you have no other idea of [why] the patient [is
referred]." Community-based cardiologist.
"If you don't like or trust that physician, it makes communica-
tion difficult, and why would you communicate with somebody
you don't trust?" Academic-affiliated cardiologist.
"I have times where I'll call the primary care physician to say,
'What exactly do you want from me?"' Academic-affiliated
cardiologist.
Gaps in screening, assessment, and diagnosis
As a consequence of inconsistent referrals and communi-
cation challenges, the cardiologists felt that they are
required to initiate a comprehensive reassessment of CV
risk among PCP-referred patients, because they do not
trust the value of referral information. In effect, they felt
forced to assume a PCP's role, because they perceive that
PCPs have an inadequate understanding of what consti-
tutes an adequate risk evaluation.
Table 3: Regional distribution
New England and Mid-
Atlantic
South Atlantic, East South 
Central, and West South 
Central
Pacific and Mountain East North Central and 
West North Central
Total
Exploratory Phase
Panel meetings 19 1 - - 20
KI interviews 4 6 4 3 17
Validation Phase
Online survey 38 38 37 37 150
Total 61 45 41 40 187BMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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The cardiologists reported that PCPs are rarely up-to-date
on recent medical literature and clinical guidelines. In
addition, PCPs were not perceived as being aggressive
enough in setting and reaching treatment goals. For exam-
ple, when reviewing antihypertensive therapy, the cardiol-
ogists reported that they often question PCP-initiated
treatment regimens and combination therapies. As a
result, cardiologists felt obliged to confront treatment
gaps among PCP-referred patients. The following state-
ment effectively summarizes these observations.
"There's an enormous gap between what physicians [PCPs]
should know and do and what they actually do. It's a very sad
state of affairs." Community cardiologist.
When asked to self-evaluate their clinical competencies,
cardiologists were confident in their knowledge and abil-
ity to assess CV risk factors. They rated their current risk-
assessment competencies as close to what they considered
to be ideal clinical practice. Table 4 delineates the sum-
mary of seven clinical-assessment practices, wherein par-
ticipants rated their current and desired competency levels
by using a 5-point Likert scale. Cardiologists did not self-
assess any areas of CV risk assessment as a substantive gap,
Table 4: Competency gaps* in CV risk assessment (n = 150)
Current Desired Gap Academic Gap Community Gap
Estimating incremental risk incurred by conditional risk factors 3.84 4.59 0.75 0.83 0.67
Estimating cardiovascular risk in primary prevention 4.14 4.75 0.61 0.73 0.48
Estimating incremental risk incurred by predisposing risk factors 4.07 4.67 0.60 0.68 0.52
Identifying conditional cardiovascular risk factors 4.07 4.65 0.59 0.67 0.51
Estimating cardiovascular risk in secondary prevention 4.29 4.75 0.46 0.56 0.36
Identifying predisposing cardiovascular risk factors 4.41 4.78 0.37 0.45 0.29
Identifying major independent cardiovascular risk factors 4.49 4.79 0.30 0.37 0.23
Self-assessment scale: 1 to 5. 1 = Low competence and 5 = High competence.
*Competency gaps are identified when the self-assessment of current competency is substantively lower than desired competency. If the gap 
between desired and current competencies is >1, then the gap is considered as substantive [18].
Barriers to positive health outcomes: referrals from primary-care physicians (n = 150) Figure 1
Barriers to positive health outcomes: referrals from primary-care physicians (n = 150).
0123
Quality of clinical information received
from PCPs when patients are referred
Appropriate cardiology referrals from
PCPs
Timing of patient referral from PCPs to
cardiologists
No barrier                                                         Large 
                                                                             barrierBMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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although some trends emerged. For example, with respect
to competencies in the assessment of conditional risk fac-
tors, cardiologists rated their competencies moderately
lower. Conditional risk factors were defined by elevated
serum triglycerides, small LDL particles, elevated serum
homocysteine, elevated serum lipoprotein, prothrom-
botic factors (e.g., fibrogen), and inflammatory markers
(e.g., C-reactive protein).
Although cardiologists are confident about their ability to
assess CV risk factors, they face barriers from the systems
in which they practice. For example, they struggle to incor-
porate the rules imposed by health maintenance organiza-
tions (HMOs) or insurance companies, who have
introduced certain limitations for CV risk-factor assess-
ment in clinical practice. As one academic-affiliated cardi-
ologist commented,
"We have to justify doing procedures in order to learn more
about the patient's risk."
In addition, some cardiologists felt obliged to order diag-
nostic tests and more in-depth assessments principally for
legal protection, rather than because these tests were med-
ically appropriate or necessary.
Treatment
Cardiologists reported three primary challenges in treat-
ing and managing patients with CV risk factors: managing
patients with multiple concomitant complications and
CV risk factors; balancing the benefits and risks of com-
plex drug regimens and modifying inappropriate drug reg-
imens of PCP-referred patients; and patient-provider
relational issues, particularly patient adherence to lifestyle
changes and medications.
Treating complex patients poses significant challenges for
cardiologists. They accepted these challenges, because
they saw it as their clinical responsibility, as specialists, to
manage these patients to achieve a balance between mul-
tiple concomitant complications and CV risk. Elderly
patients were identified as particularly complex to manage
because of the potential repercussions of reducing diasto-
lic BP too significantly. A community-based cardiologist
summarized this concern as follows: "If you talk to a neu-
rologist, we really don't know what the optimum blood
pressure for those people should be. So lowering too low
on those older patients might cause some problems with
their CNS function."
Cardiologists observed that the cost of treatment and the
impact of formularies and healthcare plans on patient
finances represent substantive barriers to optimal patient
health outcomes. The cardiologists reported that they are
often confronted with patients who cannot or are unwill-
ing to afford the medical regimen that represent best clin-
ical practice.
Cardiologists reported that medical challenges arise when
drug-related side effects impair patient safety, especially in
patients with multiple comorbidities who require com-
plex therapeutic regimens. A community-based cardiolo-
gist pointed out: "You're trying to balance achieving
normality in whatever parameters you're treating, against
their ability to achieve normality, whether it's limited by
side effects or interactions with other diseases."
Drug-related side effects also create relational challenges
for cardiologists, as side effects may substantively affect
the patient's willingness to engage in the treatment. The
cardiologists reported that they are often placed in the
position of having to sell or convince patients of the value
of treatment recommendations, a role for which they are
poorly trained and are uncomfortable.
The independent discussions of community-based and
academic-affiliated cardiologists indicated subtle differ-
ences between these groups with respect to their treatment
challenges. Community-based cardiologists expressed
more concerns about unclear treatment guidelines, partic-
ularly for patients with multiple CV risk factors. As one
community-based cardiologist noted, "If all the studies
are pretty clear, why is there a 5-point or 10-point differ-
ence [in BP targets] and [why do] different countries have
different settings in terms of the success to goal?"
Although academic-affiliated cardiologists acknowledged
some struggles with contradicting studies, they indicated
that optimal health outcomes are undermined by their
community-based colleagues' inconsistent understanding
of the importance of targeting end-organ damage for pre-
vention.
Patient management
When managing patients with CV risk factors, cardiolo-
gists appeared to face knowledge gaps in the existing sci-
ence base, contextual barriers, and legal concerns that
interfere with optimal patient health outcomes.
They reported that a substantive barrier to optimal patient
management is the lack of an effective means to monitor
CVD progression. The majority described the current
methods that are used to monitor CVD progression as
suboptimal. They reported that the most practical means
of evaluating the progression of end-organ damage is to
assess kidney function with serum creatinine or urinalysis
to detect albuminuria. They debated the clinical value of
echocardiograms to evaluate left ventricular dysfunction
and ultrasound evaluation of the carotid arteries, and they
observed that cost limits the use of these technologies.
Routine stress tests and the assessment of retinal vascular-BMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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ization were seen as optional means for monitoring the
progression of CVD. A lack of skills and knowledge gaps
in retinal evaluation were acknowledged as limitations to
the use of this method.
The cardiologists indicated that long-term management of
patients with CV risk factors is also complicated by reim-
bursement issues, which prevent them from monitoring
patients as ideally as they would like, especially after the
introduction of new therapies.
In terms of professional satisfaction, the cardiologists
rarely acknowledged that they were not interested in mon-
itoring "basic" hypertension, but they reported that many
of their colleagues avoid this responsibility. Interestingly,
academic-affiliated cardiologists pointed out that com-
munity-based cardiologists have little interest in manag-
ing hypertension, unless patients have other CV
problems, while community-based cardiologists
expressed similar views about their academic-affiliated
peers.
The role of clinical practice guidelines
Clinical practice guidelines were unanimously perceived
as being important, and reaching the recommended treat-
ment goals was seen as critical to improve patient health
outcomes. Although cardiologists recognized that guide-
lines are used as benchmarks for appropriate standards of
care, there were widely differing opinions about the genu-
ine impact of guidelines on treatment targets.
During the exploratory phase, the cardiologists often
commented that guidelines can oversimplify the clinical
realities with which they are confronted to on a daily basis
and do not integrate the most recent literature. As a result,
while embracing the value of guidelines at a high level,
most cardiologists were critical of the actual clinical value
of guidelines in their daily practices. This finding was con-
firmed in the validation phase. Overall, the findings indi-
cated that, although guidelines have imperfections and
can become a source of frustration in daily practice, cardi-
ologists believed in their clinical value for patient health
outcomes.
Cardiologists reported that they do not treat as aggres-
sively as recommended in guidelines when patients
develop side effects that impact their quality of life or
seem detrimental to their overall condition, e.g., when
hypotensive episodes cause cerebral side effects, erectile
dysfunction, or a rise in creatinine levels.
Following clinical guidelines serves as a source of legal
protection, they indicated, as this practice provides docu-
mented evidence that they have aligned their clinical prac-
tices with the standard of care. They can use this evidence
to overcome payers' minimum reimbursement criteria.
A sub-research objective of this study was to examine the
role of clinical practice guidelines in the assessment, treat-
ment, and management of CV risk factors and to under-
stand the extent to which cardiologists practice "beyond"
or "outside" of guidelines. These concepts were not prede-
fined for participants. Although cardiologists' interpreta-
tion of these terms were not always exactly the same, most
viewed "beyond" guidelines as meaning a more aggressive
approach than recommended by guidelines, while "out-
side" guidelines meant making clinical decisions to man-
age the patient not in accordance with guidelines.
Beyond guidelines
Cardiologists reported that they routinely practice
"beyond" guidelines and are more aggressive in their
approach to treatment when recent clinical data, pub-
lished after the distribution of guidelines, demonstrate
the benefits of more aggressive targets than those deline-
ated in the guidelines. They also reported that, because
they often treat patients who are at higher risk of CVD
than the typical patients in large clinical trials that support
the development of guidelines, they aim for more aggres-
sive targets in these patients.
Outside guidelines
Cardiologists acknowledged that they treat "outside"
guidelines when treatment decisions must be more indi-
vidualized. Specifically, they reported that individualized
treatment goals must be set for patients whose ethnicity
was not studied in clinical trials used to set treatment
goals, for patients who are biologically resistant to medi-
cations, for elderly patients for whom less aggressive treat-
ment goals must be set, and for patients who suffer from
severe comorbidities, such as cancer, that are more likely
to compromise a person's life expectancies than CV risk
factors.
Gaps in health outcomes due to risk assessment
Risk-reducing strategies can never completely eliminate
nor control all CV risks. After any intervention, some level
of risk remains. The concept of residual risk is used to
describe this reality.
The results of the exploratory phase showed that cardiol-
ogists are unfamiliar with and lack clear knowledge of
what constitutes residual risk. This finding was subse-
quently validated in the online survey (Figures 2 and 3).
The cardiologists reported that they rarely discuss residual
risk in academic or clinical contexts. They proposed three
definitions for this concept: the level of CV risk that
remains despite BP stabilization; patients with controlled
hypertension carry a higher risk than patients withoutBMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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hypertension; and people who have hypertension, even if
controlled, have something biologically "wrong" with
their CV system and are therefore at higher risk.
The cardiologists questioned the clinical value of residual
risk, based on the lack of supportive data, e.g., evidence
showing that a BP of 110/70 mm Hg is better than a BP of
120/80 mm Hg. They voiced concerns about the impact of
more aggressive treatment on patients' quality of life. They
were significantly concerned about the impact of treating
residual risk on the patient-physician relationship and
wondered whether they should discuss the implications
of residual risk with their patients, as they felt that such
discussions might discourage patient compliance.
Gaps in health outcomes due to patient adherence
Patient adherence to treatment recommendations was
viewed as a significant, often overriding challenge for car-
diologists. They clearly perceived that patients are the pri-
mary source of challenge to achieving optimal patient
health outcomes. They identified gaps in patient knowl-
edge or understanding of their condition, patient commit-
ment to risk-reducing behaviors and prescribed therapy,
and their own ability to engage patients in risk-reducing
strategies as barriers to optimal patient care (Figures 4).
These barriers were not perceived as being insurmounta-
ble; however, the cardiologists felt that they had a signifi-
cant impact on the patient-physician relationship. In
addition, they observed that such relationships are
becoming increasingly difficult, as patients are more
informed and more involved in treatment decisions. They
reported that a lack of transparency and accurate commu-
nication between themselves and patients are barriers to
optimal care.
The cardiologists appeared to struggle with their own con-
tribution to the patient-physician relationship and their
role in patient adherence. When asked to assess to what
extent they contributed to the physician-patient relation-
ship and influenced patients by engaging them in treat-
ment decisions, behavior change, or interventions to
enhance adherence, they reported that patient commit-
ment was a greater barrier to the attainment of these goals.
They did not seem to recognize that their skills or abilities
as healthcare professionals had an impact on the dynam-
ics of patient adherence; instead, they clearly felt as if they
were disempowered to alter these critical issues substan-
tively and are thus subject to a patients' whims.
Learning needs and commitment to professional 
development
Cardiologists expressed few if any perceived needs for
education in the areas of assessment, diagnosis, treat-
ment, and monitoring of patients with CV risk factors.
Although only moderately satisfied with their practices in
these areas of care, they did not believe that they needed
to improve and were only moderately interested in
actively pursuing educational activities.
Discussion
The needs assessment found that cardiologists face several
challenges along the continuum of care of patients with
CV risk factors, particularly in the referral process. Similar
findings were previously found where both primary care
physicians and specialists perceived their mutual commu-
nication as inadequate and often absent [19,20]. The cur-
rent study found additional challenges in risk assessment,
Cardiologists' current understanding of the concept of  "residual risk" in the context of CV risk management (n =  150) Figure 3
Cardiologists' current understanding of the concept 
of "residual risk" in the context of CV risk manage-
ment (n = 150). 1 = No idea what it means, 2 = Some 
understanding, 3 = Good understanding, 4 = Thorough 
understanding. 70% of participants have "No idea" to "Some 
understanding" of the concept of "residual risk".
No idea what it means
Some understanding
Good understanding
Thorough understanding
4 1
3
2
Cardiologists' familiarity with the concept of "residual risk" in  the context of CV risk management (n = 150) Figure 2
Cardiologists' familiarity with the concept of "resid-
ual risk" in the context of CV risk management (n = 
150). 1 = Not at all, 2 = Somewhat, 3 = Moderately, 4 = 
Strongly, 5 = Extremely. 76% of participants are "Not at all" 
to "Moderately" familiar with the notion of residual risk.
Not at all
Somewhat
Moderately
Strongly
Extremely
5
1 4
2
3BMC Medical Education 2008, 8:30 http://www.biomedcentral.com/1472-6920/8/30
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treatment of patients with multiple risk factors and
comorbidities, and patient monitoring. Cardiologists
appeared to struggle substantively with their efforts to
enhance patient adherence to CV risk-factor modification
by medical therapy or lifestyle change.
Cardiologists demonstrate areas of weakness in core com-
petencies as reflected by the American Board of Medical
Specialists that involve patient care and interpersonal
communication skills. Difficulty of physicians to discuss
diagnosis, risks or bad news is well documented across all
specialties [21,22]. Despite no evidence-based guidelines
for communicating with patients, ways to support physi-
cians communicating risk and evidence to patients have
been identified [22]. However, a key finding of this needs
assessment was that cardiologists often failed to acknowl-
edge their own knowledge, skills, attitudes, and behaviors
as barriers to optimal patient health outcomes. This find-
ing is supported by the systematic review of literature con-
ducted by Davis and colleagues in 2006 [23]. Their review
of literature suggested that physicians have a limited abil-
ity to accurately self-assess their needs, knowledge, confi-
dence, skills and competencies. This finding was
independent of level of training, specialty, and domain
assessed [23]. In the current study, cardiologists tended to
believe that barriers to optimal health outcomes were
solely derived from patients and PCPs, whose competen-
cies in the area of CV management were often questioned.
They appeared to underestimate the relevance of these fac-
tors to their own professional competency.
The finding that cardiologists are only moderately inter-
ested in educational activities poses a challenge for those
who organize CPD events that aim to improve patient
health outcomes. Historically, CPD providers have tended
to develop educational interventions to improve medical
Barriers to positive health outcomes in the treatment and management of patients at risk for cardiovascular diseases: Cardiol- ogists' ability and patients' commitment to enhance adherence (n = 150) Figure 4
Barriers to positive health outcomes in the treatment and management of patients at risk for cardiovascular diseases: Cardiol-
ogists' ability and patients' commitment to enhance adherence (n = 150).
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knowledge as opposed to interpersonal or counseling
skills, attitudes, and beliefs. Addressing attitudinal and
skill-based needs demands innovative educational strate-
gies.
Conclusion
The findings of this needs assessment reveal numerous
opportunities to generate a positive impact on patient
health outcomes in the area of CV risk assessment and
management. These opportunities include specific educa-
tional interventions, such as educational programs, mate-
rials and tools that enhance interprofessional and patient-
cardiologist communications and that facilitate a better
understanding of CVD among patients.
These findings indicate a need for targeted research into
the perspectives of patients and PCPs on these important
issues. Given the importance of the patient-physician rela-
tionship and its impact on long-term adherence, patient-
based research about cardiologists' interpersonal and
communication skills would provide critical data for
designing educational initiatives that enhance the patient-
cardiologist collaboration. CPD that incorporates strate-
gies and techniques to build cardiologists' skills and con-
fidence in addressing patient compliance, promote/
increase concordance between cardiologists and patients,
and addresses the cardiologist's responsibility for promot-
ing better patient-physician collaboration would be valu-
able for practicing cardiologists. Specific educational
interventions should:
• Clarify the value of engaging patients in a dialogue on
adherence to their recommended therapeutic regimen.
￿ Be aligned with basic tenets of effective counseling and
patient management, as outlined in the core competen-
cies established by the American Board of Medical Spe-
cialists.
￿ Provide patient educational tools to address readiness to
change/resistance among patients.
￿ Educate cardiologists about how patients think and
about the scope of a physician's influence in engaging
patients to adhere to treatment.
￿ Be directed toward facilitating patient-cardiologist inter-
actions, interprovider communications, continuity of
interaction, and sharing with family members.
￿ Shift the physician's focus of control through sessions
that target beliefs and attitudes about patient vs. physician
responsibility to increase physician confidence and
impact patient collaboration.
In order to link educational interventions with patient
health outcomes and professional satisfaction, these initi-
atives need to be pragmatic, easy to apply, and tied to
measures of success for cardiologists and patients.
To strengthen interprofessional collaboration between
cardiologists and PCPS, educational interventions should
be targeted to build local or regional standards of practice
that enhance communication, e.g., standardized referral
tools, checklists, templates, etc. Research into the PCP per-
spective on patient referral would provide a more com-
plete picture of current issues and challenges that impact
patient health outcomes.
Patient education and understanding of CV risk and the
importance of controlling major CV risk factors are critical
to long-term adherence to medical therapy or lifestyle
changes. Patient educational materials could take the
form of storyboards on CV health, CV risk, or life-out-
come scenarios. Such tools would help patients to feel in
charge of their health and assume responsibility for adher-
ence to therapy. These materials would facilitate cardiolo-
gists' influence on patient-health outcomes.
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